MCAC Supports MADIT-II Criteria; EP Testing Scuttled As Stratification Tool

Guidant's subgroup analysis demonstrating that non-inducible EP-tested patients showed lower mortality rates with ICDs over conventional therapy played a decisive factor in MCAC's endorsement of national coverage